Home › Social Anxiety Disorder › NCT06678295
Individual Factors of CBT Underlying Success
RecruitingHealthy volunteers welcome
Contributions of Self-Focused Attention to Early Warning Indicators of Cognitive Behavioral Therapy Non-Response
Who can join
Ages 18 to 45 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: Clinical sample (N=110): 1. Men and women, age 18-45 2. Treatment-seeking individuals who meet criteria for a primary DSM-5 diagnosis of primary social anxiety disorder (SAD) or body dysmorphic disorder (BDD) based on the SCID-5-RV 3. Fluent in English and willing to provide informed consent. Control sample (N=50): 1. Men and women, age 18-45 2. No current or lifetime history of psychiatric disorders, as assessed using the SCID-5-RV 3. Meet criteria for low levels of anxiety (GAD-7 score of \<8) and depression (PHQ-9 score \<10) 4. Fluent in English and willing to provide informed consent Exclusion Criteria: All groups: 1. Score \< 80 based on WRAT5 Word Reading Subtest 2. fMRI contraindications (e.g., electronic medical devices such as pacemakers, implanted defibrillators, etc.; metal implants not approved for MRI; pregnancy; claustrophobia) 2\. Active suicidal or homicidal ideation, or any features requiring a higher level of care 3. Lifetime history of manic or hypomanic episode, psychotic symptoms, traumatic brain injury, neurological disorder, pervasive developmental disorder, or attention deficit-hyperactivity disorder; active alcohol or substance use disorder in the past 6 months 4. Current use of psychotropic medications, except antidepressants taken at a stable dose for 3 months prior to study baseline 5. Previous CBT non-responder or current CBT
About the study
The purpose of this study is to understand why some individuals respond fully to cognitive behavioral therapy and others do not, based on multiple sources of data such as neural, neurocognitive, clinical, and self-report data.
What is being tested
- Cognitive Behavioral Therapy (behavioral)
Sponsor: University of Washington · Participants: 160 · Started: Oct 15, 2024
Contact the study team
- Angela Fang, PhD · Phone: (206) 616-5783
Official record on ClinicalTrials.gov — NCT06678295
Locations in the U.S.
| Washington | University of Washington, Seattle |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.